EGFR-IN-8

• Description:

  EGFR-IN-8 can be a promising candidate for further development to target EGFR TKI-resistant NSCLC. EGFR-IN-8 is a dual EGFR and c-Met inhibitor.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  662.03

• Molecular Formula:

  C32H23ClF3N7O4

• Notes:

  Research use only, not for human use.

• Receptor:

  ——

• CAS Number:

  2407957-87-1